Form 8-K

8-K — RETRACTABLE TECHNOLOGIES INC

Accession: 0001104659-26-036231

Filed: 2026-03-27

Period: 2026-03-27

CIK: 0000946563

SIC: 3841 (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS)

Item: Other Events

Item: Financial Statements and Exhibits

Documents

8-K — tm269857d1_8k.htm (Primary)

EX-99.1 — EXHIBIT 99.1 (tm269857d1_ex99-1.htm)

EX-99.2 — EXHIBIT 99.2 (tm269857d1_ex99-2.htm)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K — FORM 8-K

8-K (Primary)

Filename: tm269857d1_8k.htm · Sequence: 1

false

0000946563

2026-03-27

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities

Exchange Act of 1934

Date

of Report (Date of earliest event reported)

March 27, 2026

Retractable Technologies, Inc.

(Exact name of registrant

as specified in its charter)

Texas

001-16465

75-2599762

(State or other jurisdiction

(Commission

(IRS Employer

of incorporation)

File Number)

Identification No.)

511

Lobo Lane, Little

Elm, Texas

75068-5295

(Address of principal executive

offices)

(Zip Code)

Registrant's

telephone number, including area code

(972)

294-1010

None

(Former name or former address, if changed since

last report)

Check the appropriate box below if the Form 8-K

filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General

Instruction A.2. below):

¨ Written

communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting

material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement

communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement

communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b)

of the Act:

Title

of each class

Trading

Symbol(s)

Name

of each exchange on which registered

Common

Stock

RVP

NYSE

American

Indicate by check mark whether the registrant

is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the

Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging

growth company ¨

an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying

with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨

Item 8.01 Other Events.

On March 27, 2026, the

Company issued a press release, a copy of which is attached to this Form 8-K as Exhibit 99.1, announcing results for 2025.

On March 27, 2026, the

Company issued a press release, a copy of which is attached to this Form 8-K as Exhibit 99.2, announcing the declaration of

a dividend to the Series II and Series III Class B Convertible Preferred Stock shareholders.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

99.1 Press release announcing results for 2025.

99.2 Press release announcing the declaration of a dividend to the Series II and Series III Class B

Convertible Preferred Stock shareholders.

104 Cover Page Interactive Date File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements

of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto

duly authorized.

DATE: March 27, 2026

RETRACTABLE TECHNOLOGIES, INC.

(Registrant)

BY:

/s/ JOHN W. FORT III

JOHN W. FORT III

VICE PRESIDENT, CHIEF FINANCIAL OFFICER, AND CHIEF ACCOUNTING OFFICER

EX-99.1 — EXHIBIT 99.1

EX-99.1

Filename: tm269857d1_ex99-1.htm · Sequence: 2

Exhibit 99.1

RETRACTABLE TECHNOLOGIES, INC. REPORTS

RESULTS FOR 2025

LITTLE ELM, Texas, March 27, 2026—Retractable

Technologies, Inc. (NYSE American: RVP) reports the following information relating to the year ended December 31, 2025. Further

details concerning the results of operations as well as other matters are available in Retractable’s Form 10-K filed on March 27,

2026 with the U.S. Securities and Exchange Commission.

The Company’s revenues for 2025 increased

15.8%. The Company’s revenues were approximately $38.3 million in 2025 as compared to approximately $33.0 million in the prior

year. Domestic revenues increased 9.7% principally due to an increase in VanishPoint® and EasyPoint®

needle sales. International revenues increased 64.0% predominantly due to higher EasyPoint® needle sales. Comparability

of 2025 to 2020-2023 financial results is challenging due to the unusual volume of pandemic sales in those years.

The Company’s operating costs remain high

since its facility expansion and, more recently, an increase in domestic production in connection with 2024-2026 tariffs. Total

operating expenses were $21.2 million in 2025. The 2025 loss from operations was $21.2 million as compared to a loss from operations

of $21.1 million in the prior year.

The net decrease in cash for 2025 was $1.6 million.

At the end of 2025, the Company’s cash position was $2.6 million, and the Company held $34.4 million in debt and equity securities.

Approximately $1.8 million was incurred in tariff

expense in 2025. The Company obtained 62.6% of its products from manufacturers in China. As of March 9, 2026, the prevailing

tariff rate on most syringe and needle products imported from China was 120%. As foreign trade policy continues to evolve, uncertainty

as to future tariff rates remains. Management expects that tariffs will continue to have a material impact on the Company’s operations

and financial position.

ABOUT RETRACTABLE

Retractable manufactures and markets VanishPoint®

and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe,

blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly

from the patient, effectively reducing exposure to the contaminated needle. Patient Safe® syringes are uniquely designed

to reduce the risk of bloodstream infections resulting from catheter hub contamination. The EasyPoint® is a retractable

needle that can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections. The EasyPoint®

needle also can be used to aspirate fluids and for blood collection. Retractable's products are distributed by various specialty and general

line distributors.

For more information on Retractable, visit its

website at www.retractable.com.

Forward-looking statements in this press release

are made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995 and reflect Retractable's current

views with respect to future events. Retractable believes that the expectations reflected in such forward-looking statements are accurate.

However, Retractable cannot assure you that such expectations will materialize. Actual future performance could differ materially from

such statements.

Factors that could cause or contribute to such

differences include, but are not limited to: tariffs; material changes in demand, Retractable's ability to maintain liquidity; Retractable's

maintenance of patent protection; Retractable's ability to maintain favorable third party manufacturing and supplier arrangements and

relationships; foreign trade risk; Retractable's ability to access the market; production costs; the impact of larger market players in

providing devices to the safety market; and other risks and uncertainties that are detailed from time to time in Retractable's periodic

reports filed with the U.S. Securities and Exchange Commission.

Retractable Technologies, Inc.

John W. Fort III, 888-806-2626 or 972-294-1010

Vice President, Chief Financial Officer, and Chief

Accounting Officer

EX-99.2 — EXHIBIT 99.2

EX-99.2

Filename: tm269857d1_ex99-2.htm · Sequence: 3

Exhibit 99.2

RETRACTABLE TECHNOLOGIES, INC. DECLARES

DIVIDENDS TO SERIES II AND III CLASS B PREFERRED STOCK SHAREHOLDERS

LITTLE ELM, Texas, March 27, 2026 —

Retractable Technologies, Inc. (“Retractable”) (NYSE American: RVP) announced today that its Board of Directors has declared

dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of

$39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning

January 1, 2026 through March 31, 2026. The dividends will be paid on April 20, 2026 to shareholders of record as of the

close of business on April 10, 2026.

Retractable manufactures and markets VanishPoint®

and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe,

blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly

from the patient, effectively reducing exposure to the contaminated needle. Patient Safe® syringes are uniquely designed

to reduce the risk of bloodstream infections resulting from catheter hub contamination. The EasyPoint® is a retractable

needle that can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections. The EasyPoint®

needle also can be used to aspirate fluids and for blood collection. Retractable's products are distributed by various specialty and general

line distributors.

For more information on Retractable, visit its

website at www.retractable.com.

Forward-looking statements in this press release

are made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995 and reflect Retractable's current

views with respect to future events. Retractable believes that the expectations reflected in such forward-looking statements are accurate.

However, Retractable cannot assure you that such expectations will materialize. Actual future performance could differ materially from

such statements.

Factors that could cause or contribute to such

differences include, but are not limited to: tariffs; material changes in demand, Retractable's ability to maintain liquidity; Retractable's

maintenance of patent protection; Retractable's ability to maintain favorable third party manufacturing and supplier arrangements and

relationships; foreign trade risk; Retractable's ability to access the market; production costs; the impact of larger market players in

providing devices to the safety market; and other risks and uncertainties that are detailed from time to time in Retractable's periodic

reports filed with the U.S. Securities and Exchange Commission.

Retractable Technologies, Inc.

John W. Fort III, 888-806-2626 or 972-294-1010

Vice President, Chief Financial Officer, and Chief

Accounting Officer

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 8

v3.26.1

Cover

Mar. 27, 2026

Cover [Abstract]

Document Type

8-K

Amendment Flag

false

Document Period End Date

Mar. 27, 2026

Entity File Number

001-16465

Entity Registrant Name

Retractable Technologies, Inc.

Entity Central Index Key

0000946563

Entity Tax Identification Number

75-2599762

Entity Incorporation, State or Country Code

Entity Address, Address Line One

511

Lobo Lane

Entity Address, City or Town

Little

Elm

Entity Address, State or Province

Entity Address, Postal Zip Code

75068-5295

City Area Code

972

Local Phone Number

294-1010

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Title of 12(b) Security

Common

Stock

Trading Symbol

RVP

Security Exchange Name

NYSEAMER

Entity Emerging Growth Company

false

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration